Research location

Bouge

Belgium

Published trials14
Site observations14
Linked trials published14
Page1 / 1
Advertisement

Research activity in Bouge

Belgium

CureCurrent currently publishes aggregate city-level research activity for this location: 14 trials and 14 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Bouge

14 linked trials · page 1 of 1
A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With NeratinibNCT05599334 · 2022-07-05 · 1 site observation
COMPLETED
Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in BelgiumNCT03761901 · 2018-09-21 · 1 site observation
COMPLETED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
A Study of Oral CFG920 in Patients With Castration Resistant Prostate CancerNCT01647789 · 2012-12-04 · 1 site observation
TERMINATED
Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With AnthracyclinesNCT01555944 · 2012-02-01 · 1 site observation
COMPLETED
A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))NCT01342913 · 2011-02-01 · 1 site observation
COMPLETED
Evaluation of the BRADA and ABILHAND QuestionnairesNCT00938444 · 2009-06-01 · 1 site observation
COMPLETED
A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II DisorderNCT00888264 · 2009-05-01 · 1 site observation
COMPLETED
Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung CancerNCT00864266 · 2009-03-01 · 1 site observation
COMPLETED
An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung CancerNCT01161173 · 2008-04-01 · 1 site observation
COMPLETED
Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung CancerNCT00633568 · 2007-01-01 · 1 site observation
TERMINATED
A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast CancerNCT00649090 · 2005-03-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic CancerNCT00541281 · 2003-12-01 · 1 site observation
COMPLETED
Crestor Versus Placebo in Subjects With Heart FailureNCT00206310 · 2003-09-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.